Management of multiple sclerosis in primary and secondary care. National Institute for Healthcare and Excellence (NICE). NICE guidelines [CG186], 2014. Accessed https://www.nice.org.uk/guidance/cg186. Accessed June 2014.
Cortese I, Chaudhry V, So YT, et al. Evidence-based guideline update: Plasmapheresis in neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, January 18, 2011, 76(3), 294-300. http://www.neurology.org/content/76/3/294.full.html. Accessed August 2016.
Lublin FD, Rheingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology, July 15, 2014, 10-1212. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117366/. Accessed August 2016.
MS the disease. National Multiple Sclerosis Society. http://www.nationalmssociety.org/press-room/ms-the-disease/index.aspx. Accessed August 2016.